These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 15681834)

  • 1. A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia.
    Yepes M; Brown SA; Moore EG; Smith EP; Lawrence DA; Winkles JA
    Am J Pathol; 2005 Feb; 166(2):511-20. PubMed ID: 15681834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
    Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
    Echeverry R; Wu F; Haile WB; Wu J; Yepes M
    J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
    Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M
    Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration.
    Potrovita I; Zhang W; Burkly L; Hahm K; Lincecum J; Wang MZ; Maurer MH; Rossner M; Schneider A; Schwaninger M
    J Neurosci; 2004 Sep; 24(38):8237-44. PubMed ID: 15385607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.
    Inta I; Frauenknecht K; Dörr H; Kohlhof P; Rabsilber T; Auffarth GU; Burkly L; Mittelbronn M; Hahm K; Sommer C; Schwaninger M
    J Neurol Sci; 2008 Dec; 275(1-2):117-20. PubMed ID: 18793781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
    Haile WB; Echeverry R; Wu J; Yepes M
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation.
    Polavarapu R; Gongora MC; Winkles JA; Yepes M
    J Neurosci; 2005 Nov; 25(44):10094-100. PubMed ID: 16267216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice.
    Wen J; Chen CH; Stock A; Doerner J; Gulinello M; Putterman C
    Brain Behav Immun; 2016 May; 54():27-37. PubMed ID: 26721417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice.
    Ho DH; Vu H; Brown SA; Donohue PJ; Hanscom HN; Winkles JA
    Cancer Res; 2004 Dec; 64(24):8968-72. PubMed ID: 15604260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.
    Kawashima R; Kawamura YI; Oshio T; Son A; Yamazaki M; Hagiwara T; Okada T; Inagaki-Ohara K; Wu P; Szak S; Kawamura YJ; Konishi F; Miyake O; Yano H; Saito Y; Burkly LC; Dohi T
    Gastroenterology; 2011 Dec; 141(6):2119-2129.e8. PubMed ID: 21893119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
    Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
    J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.
    Yepes M; Winkles JA
    Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
    Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
    Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
    Campbell S; Burkly LC; Gao HX; Berman JW; Su L; Browning B; Zheng T; Schiffer L; Michaelson JS; Putterman C
    J Immunol; 2006 Feb; 176(3):1889-98. PubMed ID: 16424220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
    Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
    Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
    Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
    Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity.
    Donohue PJ; Richards CM; Brown SA; Hanscom HN; Buschman J; Thangada S; Hla T; Williams MS; Winkles JA
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):594-600. PubMed ID: 12615668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization.
    De A; Park JI; Kawamura K; Chen R; Klein C; Rauch R; Mulders SM; Sollewijn Gelpke MD; Hsueh AJ
    Mol Endocrinol; 2006 Oct; 20(10):2528-38. PubMed ID: 16762976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.